Publications Details for:

Inhalation and Dermal Exposure to Disinfection By-Products of Chlorinated Drinking Water
Grant Number R825953
RFA: Drinking Water (1997)
Journal Article (5)
Presentation (8)
Reference Type Citation Progress Report Year Document Sources
Journal Article Kim HK, Weisel CP. Dermal absorption of dichloro-and trichloroacetic acids from chlorinated water. J Exposure Anal Environ Epidemiology 1998;8(4):555-575. R825953 (1998)
not available
Journal Article Xu X, Mariano TM, Laskin JD, Weisel CP. Percutaneous absorption of trihalomethanes, haloacetic acids, and haloketones. Toxicology and Applied Pharmacology 2002;184(1):19-26. R825953 (Final)
Journal Article Xu X, Weisel CP. Inhalation exposure to haloacetic acids and haloketones during showering. Environmental Science & Technology 2003;37(3):569-576. R825953 (Final)
Journal Article Xu X, Weisel CP. Human respiratory uptake of chloroform and haloketones during showering. Journal of Exposure Analysis and Environmental Epidemiology 2005;15(1):6-16. R825953 (Final)
Journal Article Xu X, Weisel CP. Dermal uptake of chloroform and haloketones during bathing. Journal of Exposure Analysis and Environmental Epidemiology 2005;15(4):289-296. R825953 (Final)
Presentation Trabaris M, Xu X, Laskin J, Mariano T, Weisel CP. In vitro dermal exposure assessment of drinking water disinfection by-products. Presented at the American Water Works Association Microbial/Disinfection By-Products Health Effects Symposium, Lisle, IL, March 24-26, 2001. R825953 (Final)
not available
Presentation Trabaris M, Weisel CP. Dermal and inhalation exposures to haloacetonitriles and chloral hydrate in drinking water during showering and bathing. Presented at the 11th Annual Meeting of the International Society of Exposure Analysis, Charleston, SC, November 4-8, 2001. R825953 (Final)
not available
Presentation Weisel CP. Human exposure assessment: biomarkers of exposure. Presented at the Second International Conference on the Safety of Water Disinfection: Balancing Chemical and Microbial Risks, International Life Sciences Institute, ILSI0, Miami, FL, November 15-17, 1999. R825953 (1999)
R825953 (Final)
not available
Presentation Weisel CP. Biomarkers of exposures to DBPs. Presented at the Exposure Assessment for Disinfection By-Products in Epidemiologic Studies Conference, Ottawa, Canada, May 7-10, 2000. R825953 (Final)
not available
Presentation Weisel CP, Xu X, Trabaris M. Inhalation and dermal exposure to the DBPs haloacetic acids, halopropanones, haloacetonitriles and chloral hydrate. Presented at the 14th Conference of the International Society of Environmental Epidemiology, University of British Columbia, Vancouver, British Columbia, Canada, August 11-15, 2002. R825953 (Final)
not available
Presentation Weisel CP, Xu X, Trabaris M. Inhalation and dermal exposure to the DBPs haloacetic acids, halopropanones, haloacetonitriles and chloral hydrate. Presented at the 12th Annual Meeting of the International Society of Exposure Analysis, University of British Columbia, Vancouver, British Columbia, Canada, August 11-15, 2002. R825953 (Final)
not available
Presentation Xu X, Fesenmaier C, Weisel CP. Assessment of exposure to haloacetone and haloacetic acids in aerosols during showering. Presented at the American Water Works Association Microbial/Disinfection By-Products Health Effects Symposium, Lisle, IL, March 24-26, 2001. R825953 (Final)
not available
Presentation Xu X, Weisel CP, Mariano T, Laskin JD. Percutaneous absorption of halogenated disinfection byproducts through human skin: in vitro experiments and GC/ECD determination. Presented at the 11th Annual Meeting of the International Society of Exposure Analysis, Charleston, SC, November 4-8, 2001. R825953 (Final)
not available